DJIA52380.66 0.00
S&P 5007636.36 -37.16
NASDAQ26253.34 -168.07
Russell 20002921.23 -38.97
German DAX25576.45 -431.18
FTSE 10010670.06 -141.60
CAC 408156.67 -161.31
EuroStoxx 506311.75 -101.40
Nikkei 22565270.95 128.17
Hang Seng25274.96 -42.22
Shanghai Comp3951.51 10.96
KOSPI7033.92 -17.72
Bloomberg Comm IDX145.14 0.00
WTI Crude-fut99.59 1.74
Brent Crude-fut100.05 2.97
Natural Gas2.79 -0.01
Gasoline-fut3.29 0.07
Gold-fut4412.00 -34.00
Silver-fut65.93 -1.99
Platinum-fut1826.40 -78.00
Palladium-fut1316.50 -53.50
Copper-fut6.56 -0.30
Aluminum-spot3195.00 0.00
Coffee-fut284.10 -7.05
Soybeans-fut1320.00 11.25
Wheat-fut734.50 5.75
Bitcoin77284.28 -713.24
Ethereum USD2442.52 -10.44
Litecoin52.29 -0.61
Dogecoin0.09 0.00
EUR/USD1.1631 0.0010
USD/JPY153.50 -0.59
GBP/USD1.3550 0.0014
USD/CHF0.8108 0.0010
USD IDX99.01 0.26
US 10-Yr TR4.907 0.067
GER 10-Yr TR3.4756 0.0375
UK 10-Yr TR5.3288 0.061
JAP 10-Yr TR2.925 0.015
Fed Funds3.75 0
SOFR3.64 0
High-rise commercial buildings

Sub Markets

Topics

Direct Investment  + M&As  | 
Brookfield, CDPQ Complete $1.34B Acquisition of Antylia Scientific, Expanding Life Sciences Investment 

Brookfield, CDPQ Complete $1.34B Acquisition of Antylia Scientific, Expanding Life Sciences Investment 

Brookfield Asset Management and Caisse de dépôt et placement du Québec (CDPQ) have completed the acquisition of Antylia Scientific for approximately $1.34 billion, concluding a decade-long ownership by private equity firm GTCR. The transaction marks another significant industrial investment for Brookfield, following its $1.7 billion acquisition of Chemelex earlier this year. 

Based in Vernon Hills, Illinois, Antylia Scientific provides essential consumables and testing equipment for diagnostic, environmental, and life sciences laboratories. Since GTCR’s initial acquisition in 2014—then known as Cole-Parmer Instrument Company in a carve-out from Thermo Fisher Scientific—Antylia has undergone substantial transformation. GTCR supported 15 strategic add-on acquisitions and divested the Masterflex bioprocessing segment in a $2.9 billion sale to Avantor in 2021. 

Brookfield Private Equity Group CEO Anuj Ranjan noted plans to enhance Antylia’s growth through improvements in commercial strategy and procurement. CDPQ’s Martin Longchamps emphasized the company’s role in supporting mission-critical industries. 

Goldman Sachs and Jefferies advised Antylia on the deal, with legal counsel from Kirkland & Ellis. GTCR was advised by J.P. Morgan Securities.  

Connect

Inside The Story

Brookfield Asset ManagementCaisse de dépôt et placement du Québec (CDPQ)Antylia

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.